(Q38195792)

30 August 2017

1 reference

title

Somatostatin and diabetic retinopathy: current concepts and new therapeutic perspectives (English)

1 reference

30 August 2017

1 reference

Cristina Hernández

1

1 reference

30 August 2017

Olga Simó-Servat

series ordinal

2

1 reference

30 August 2017

Rafael Simó

series ordinal

3

1 reference

30 August 2017

publication date

14 March 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

46

1 reference

30 August 2017

issue

2

1 reference

30 August 2017

page(s)

209-214

1 reference

https://scigraph.springernature.com/pub.10.1007/s12020-014-0232-z

30 August 2017

exact match

0 references

cites work

Global prevalence and major risk factors of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Direct and indirect costs among employees with diabetic retinopathy in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Novel modalities of somatostatin actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Somatostatin-like immunoreactivity in the retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Multiple Forms of Immunoreactive Somatostatin: Comparison of Distribution in Neural and Nonneural Tissues and Portal Plasma of the Rat*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Somatostatin mRNA and molecular forms during development of the rat retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Somatostatin-like immunoreactive material in the rabbit retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Somatostatin molecular variants in the vitreous fluid: a comparative study between diabetic patients with proliferative diabetic retinopathy and nondiabetic control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Somatostatin and somatostatin receptors in retinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Facilitation of GABAergic signaling in the retina by receptors stimulating adenylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients: possible role in the development of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Classification and nomenclature of somatostatin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Octreotide for acromegaly treatment: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Cross-talk and modulation of signaling between somatostatin and growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Molecular biology of somatostatin receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

A cortical neuropeptide with neuronal depressant and sleep-modulating properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Retinal ganglion cells in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Retinal glutamate in diabetes and effect of antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

A role for excitatory amino acids in diabetic eye disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Expression of glutamate receptors and calcium-binding proteins in the retina of streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Upregulation of glutamate-aspartate transporter by glial cell line-derived neurotrophic factor ameliorates cell apoptosis in neural retina in streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Functional correlates of somatostatin receptor 2 overexpression in the retina of mice with genetic deletion of somatostatin receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Somatostatin inhibits potassium-evoked glutamate release by activation of the sst(2) somatostatin receptor in the mouse retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Somatostatin modulates dopamine release in rat retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Somatostatin receptors in wildtype and somatostatin deficient mice and their involvement in nitric oxide physiology in the retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Somatostatin receptors (sst2) regulate cGMP production in rat retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Effect of intravitreal administration of somatostatin and sst2 analogs on AMPA-induced neurotoxicity in rat retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Retinal ischemia: mechanisms of damage and potential therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Pasireotide (SOM230) protects the retina in animal models of ischemia induced retinopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Effect of somatostatin analogues on chemically induced ischaemia in the rat retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Modulation of the neuronal response to ischaemia by somatostatin analogues in wild-type and knock-out mouse retinas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Vascular endothelial growth factor in the ischemic retina and its regulation by somatostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Activation of somatostatin receptor (sst 5) protects the rat retina from AMPA-induced neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

A brief review of the pharmacologic and therapeutic aspects of memantine in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

The therapeutic problem of proliferative diabetic retinopathy: targeting somatostatin receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Modulation of retinal endothelial cell behaviour by insulin-like growth factor I and somatostatin analogues: implications for diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Octreotide prevents growth factor-induced proliferation of bovine retinal endothelial cells under hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Nonpeptide somatostatin receptor agonists specifically target ocular neovascularization via the somatostatin type 2 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Mimicking microvascular alterations of human diabetic retinopathy: a challenge for the mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Octreotide reduces vitreous hemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Sandostatin LAR for cystoid diabetic macular edema: a 1-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Lanreotide Autogel for persistent diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Circulating IGF-I and its protective role in the pathogenesis of diabetic angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Medical treatment of diabetic retinopathy with somatostatin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

IGF-I mRNA and signaling in the diabetic retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Strategies for blocking angiogenesis in diabetic retinopathy: from basic science to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0232-Z

Characterization of somatostatin-like immunoreactivity in vertebrate retinas

21 January 2018

1 reference

12 December 2020

Lowered cortistatin expression is an early event in the human diabetic retina and is associated with apoptosis and glial activation

1 reference

12 December 2020

Mechanisms underlying somatostatin receptor 2 down-regulation of vascular endothelial growth factor expression in response to hypoxia in mouse retinal explants

1 reference

12 December 2020

Does insulin-like growth factor I predict incidence and progression of diabetic retinopathy?

1 reference

12 December 2020

Somatostatin receptor 2A expression in choroidal neovascularization secondary to age-related macular degeneration.

1 reference

12 December 2020

Antiangiogenic role of somatostatin receptor 2 in a model of hypoxia-induced neovascularization in the retina: results from transgenic mice

1 reference

12 December 2020

Localization, chromatographic characterization, and development of somatostatin-like immunoreactivity in the guinea pig retina.

1 reference

12 December 2020

Diabetes changes the levels of ionotropic glutamate receptors in the rat retina.

1 reference

12 December 2020

Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group

1 reference

12 December 2020

Changes in neuronal response to ischemia in retinas with genetic alterations of somatostatin receptor expression

1 reference

12 December 2020

Structure of somatostatin isolated from bovine retina

1 reference

12 December 2020

Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target?

1 reference

12 December 2020

Essential role of growth hormone in ischemia-induced retinal neovascularization

1 reference

12 December 2020

Diabetes reduces glutamate oxidation and glutamine synthesis in the retina. The Penn State Retina Research Group

1 reference

12 December 2020

Role of somatostatin-14 and its analogues in the management of gastrointestinal fistulae: clinical data

1 reference

12 December 2020

1 reference

12 December 2020

Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5).

1 reference

12 December 2020

Deficit of somatostatin in the vitreous fluid of patients with diabetic macular edema

1 reference

12 December 2020

Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy

1 reference

12 December 2020

Somatostatin modulates voltage-gated K(+) and Ca(2+) currents in rod and cone photoreceptors of the salamander retina

1 reference

12 December 2020

Targeting intraocular neovascularization and edema--one drop at a time

1 reference

12 December 2020

Somatostatin as a modulator of distal nephron water permeability

1 reference

12 December 2020

Biosynthesis of somatostatin-like immunoreactivity by frog retinas in vitro

1 reference

12 December 2020

10.1007/S12020-014-0232-Z

Identifiers

DOI

1 reference

30 August 2017

1 reference